We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.9B
AUM Growth
+$1.75B
(+7.2%)
Cap. Flow
+$434M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
23.48%
Holding
1,080
New
134
Increased
325
Reduced
445
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$189M |
| 2 |
Intel
INTC
|
+$180M |
| 3 |
Amphenol
APH
|
+$132M |
| 4 |
Intuit
INTU
|
+$106M |
| 5 |
Southwest Airlines
LUV
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$221M |
| 2 |
Constellation Energy
CEG
|
+$181M |
| 3 |
Uber
UBER
|
+$169M |
| 4 |
Mastercard
MA
|
+$140M |
| 5 |
Exelon
EXC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.39% |
| 2 | Financials | 14.25% |
| 3 | Consumer Discretionary | 12.97% |
| 4 | Industrials | 12.61% |
| 5 | Healthcare | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Resources Connection
RGP
$136M
| $5.56M | 0.02% |
573,235
+29,969
| +6% | +$310K |
|
427
Fate Therapeutics
FATE
$270M
| $5.56M | 0.02% |
1,587,900
-106,317
| -6% | -$414K |
|
428
Towne Bank
TOWN
$3.53B
| $5.48M | 0.02% |
165,787
-43,754
| -21% | -$1.41M |
|
429
Alpha and Omega Semiconductor
AOSL
$863M
| $5.47M | 0.02% |
147,383
-1,717
| -1% | -$65.2K |
|
430
Mueller Industries
MLI
$14.7B
| $5.46M | 0.02% |
+147,350
| New | +$4.94M |
|
431
US Foods
USFD
$22.3B
| $5.45M | 0.02% |
+88,552
| New | +$4.96M |
|
432
Ultragenyx Pharmaceutical
RARE
$2.56B
| $5.44M | 0.02% |
97,960
-536,367
| -85% | -$27.3M |
|
433
Enova International
ENVA
$6.2B
| $5.42M | 0.02% |
64,702
-1,701
| -3% | -$132K |
|
434
Covenant Logistics
CVLG
$1.09B
| $5.36M | 0.02% |
202,918
-946
| -0.5% | -$24.5K |
|
435
Eagle Materials
EXP
$6.86B
| $5.33M | 0.02% |
18,538
-117,261
| -86% | -$29.3M |
|
436
Genesco
GCO
$432M
| $5.28M | 0.02% |
194,492
-30,742
| -14% | -$854K |
|
437
Safety Insurance
SAFT
$1.51B
| $5.25M | 0.02% |
64,198
-370
| -0.6% | -$30.4K |
|
438
Phillips Edison & Co
PECO
$5.48B
| $5.25M | 0.02% |
139,146
+118,640
| +579% | +$4.23M |
|
439
HealthStream
HSTM
$843M
| $5.24M | 0.02% |
181,648
-7,718
| -4% | -$221K |
|
440
V2X
VVX
$2.82B
| $5.23M | 0.02% |
+93,601
| New | +$4.77M |
|
441
Ryan Specialty Holdings
RYAN
$5.96B
| $5.16M | 0.02% |
77,678
-248,829
| -76% | -$15.5M |
|
|
NARI
442
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $5.06M | 0.02% |
122,722
-103,421
| -46% | -$4.97M |
|
|
FFWM
443
DELISTED
First Foundation Inc
FFWM
| $4.89M | 0.02% |
784,227
-222,645
| -22% | -$1.42M |
|
444
Domo
DOMO
$177M
| $4.87M | 0.02% |
648,649
-6,231
| -1% | -$47.6K |
|
|
ZEUS
445
DELISTED
Olympic Steel
ZEUS
| $4.79M | 0.02% |
122,773
-1,136
| -0.9% | -$47.8K |
|
446
Merchants Bancorp
MBIN
$2.24B
| $4.79M | 0.02% |
106,484
-30,938
| -23% | -$1.37M |
|
447
ESAB
ESAB
$5.54B
| $4.76M | 0.02% |
44,743
-12,869
| -22% | -$1.27M |
|
448
Trinity Industries
TRN
$3.03B
| $4.74M | 0.02% |
136,192
-1,517
| -1% | -$48.7K |
|
449
Alector
ALEC
$169M
| $4.74M | 0.02% |
1,017,687
+159,111
| +19% | +$853K |
|
450
MasterCraft Boat Holdings
MCFT
$607M
| $4.69M | 0.02% |
257,401
-4,366
| -2% | -$83K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2024 Portfolio in Review
As of Q3 2024, Jacobs Levy Equity Management held 1,080 positions worth $25.9B, up 7.2% from $24.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management's Q3 2024 filing shows 134 new, 325 increased, 445 reduced and 139 closed positions. Its largest new stake was Lam Research: 962,880 shares worth $78.6M. The largest sale was Fortinet, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2024 buy was Lam Research: 962,880 shares worth $78.6M.
- Jacobs Levy Equity Management added most to Edwards Lifesciences in Q3 2024, an estimated $189M increase.
- Jacobs Levy Equity Management's biggest Q3 2024 reduction was Fortinet, cutting an estimated $221M.
- Jacobs Levy Equity Management fully exited Smartsheet Inc. in Q3 2024, selling an estimated $81.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $25.9B portfolio in Q3 2024.
- Jacobs Levy Equity Management opened 134 new positions and closed 139 in Q3 2024.
- Jacobs Levy Equity Management's portfolio value rose 7.2% quarter-over-quarter to $25.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.